Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers M > Headlines for Mithra Pharmaceuticals SA > News item |
Mithra lowers conversion price for convertible bonds due 2025
By Marisa Wong
Los Angeles, July 5 – Mithra Pharmaceuticals SA adjusted the conversion price on its €125 million senior convertible bonds due 2025 (ISIN: BE6325746855), according to a Tuesday press release.
The conversion price was decreased to €24.1256 from €24.5425, effective as of Nov. 22, 2022.
The adjustment is a result of the company drawing a second tranche under its senior secured convertible facilities agreement and conversion agreement dated Aug. 8, 2022. The drawdown was announced on Oct. 31, 2022.
Mithra is a Liege, Belgium-based biopharmaceutical company focused on women’s health.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.